Japan stock market week to June 8, 2009

8 June 2009

Tokyo continued a three-week upturn in the review period to June 8. The Nikkei 225 was up 1.9% to close at 9865.63, a new eight-month high,  while the Topix Index rose 1.6%. There was persistent hope for an early  economic recovery in Japan, fueled by a positive comment from the  Japanese Finance Minister that the economy had bottomed-out during the  January-March quarter. However, investors saw a dearth of fresh domestic  incentives and realized that the recent Japanese market development was  largely influenced by external factors and news, such as the start of US  car maker General Motor's initiation of reconstruction under government  backing, as well as foreign exchanges. Reflecting the yen's fall,  export-oriented issues drew buying attention. The pharmaceutical index  ended down 2.8%, underperforming the market.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >






Company Spotlight